Your fact-checks will appear here
Ivermectin is not approved by the FDA to treat cancer, and higher dosing has known toxicity risks.
Only a single actively registered randomized or early-phase trial of ivermectin in human cancer patients is clearly documented in the available reporting: a phase I/II study combining oral ivermectin ...
Ivermectin in 2025 is a well-established antiparasitic medicine with specific, approved human indications and weight‑based dosing regimens; it is not approved for COVID‑19 or cancer and can be dangero...
is an ‑approved antiparasitic medicine in the for specific human and certain ; the common oral human dosing is weight‑based, typically 200 micrograms per kilogram given as a single dose for approved s...
is an antiparasitic medicine with a small set of FDA‑approved, “on‑label” human uses—oral formulations for certain parasitic worms and topical formulations for skin and lice—while a range of other app...